Worldquant Millennium Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Worldquant Millennium Advisors LLC

$13.6 Billion
Q3 2024

A detailed history of Worldquant Millennium Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Worldquant Millennium Advisors LLC holds 121,275 shares of REGN stock, worth $85.1 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

121,275

Holding current value

$85.1 Million

% of portfolio

0.94%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $124 Million - $146 Million	121,275 New	121,275 $127 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $946,921 - $1.04 Million	-1,049 Reduced 70.03%	449 $432,000
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $12.2 Million - $13.8 Million	-15,682 Reduced 91.28%	1,498 $1.32 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $419,624 - $511,688	606 Added 3.66%	17,180 $14.1 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $3.58 Million - $4.25 Million	-5,121 Reduced 23.6%	16,574 $11.9 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $14.8 Million - $17.9 Million	21,695 New	21,695 $17.8 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $27 Million - $31.6 Million	-45,312 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $21.1 Million - $26.1 Million	38,879 Added 604.37%	45,312 $28.6 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $3.69 Million - $4.38 Million	6,433 New	6,433 $3.89 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $5.89 Million - $6.95 Million	-12,449 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $5.56 Million - $6.82 Million	12,449 New	12,449 $5.89 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $2 Million - $2.54 Million	-4,175 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $1.79 Million - $2.16 Million	-3,284 Reduced 44.03%	4,175 $2.34 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $1.16 Million - $1.52 Million	-2,361 Reduced 24.04%	7,459 $4.65 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $3.3 Million - $4.86 Million	9,820 New	9,820 $4.8 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $13.8 Million - $16 Million	-39,286 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $11.2 Million - $13.6 Million	39,286 New	39,286 $13.6 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.

Account

Worldquant Millennium Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History